HEALTH● LOWAug 20 · Aug 20, 2026, 6:30 PM
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
GNN Science
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high risk. Pancreatic cancer has one of the lowest survival rates of any form, and the developers believe […] The post Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk appeared first on Good News Network.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoFrance reports first human case of livestock virus ShamondaIrish Times WorldHEALTH45m agoHealth authorities race to investigate first human death linked to rare cattle virusThe TelegraphHEALTH49m agoFirst human infected with livestock disease shamondavirus, French patient deceasedNOS BuitenlandHEALTH53m agoHuman Shamonda Virus: Reported Case Has No Health Risk, Says FranceChannels TV